FDA Investigator: Qin Xu
- Qin Xu first started conducting FDA inspections in 2014, with the last inspection in 2019. Over that time, Qin Xu has conducted 62 inspections at 59 companies across 60 sites.
Documents
FDA 483 AstraZeneca Pharmaceuticals, Frederick | August 2018
Available - $199
Qin Xu
Human Drug Form 483
FDA 483 IntelliPharmaCeutics Corp., Etobicoke | 2019
Out-of-stock
Qin Xu
Human Drug Form 483
FDA 483 ANI Pharmaceuticals Canada, Inc., Oakville | 2019
Out-of-stock
Qin Xu
Human Drug Form 483
FDA 483 Eurofins Dr. Specht Laboratorien, GmbH, Hamburg | 2018
Out-of-stock
Qin Xu
Human Drug Form 483
FDA 483 GP Grenzach Produktions GmbH, Grenzach-Wyhlen | 2018
Out-of-stock
Qin Xu
Human Drug Form 483
FDA 483 Eisai, Inc., Baltimore | 2016
Out-of-stock
Qin Xu
Human Drug Form 483
FDA 483 China Ningbo Shangge Cosmetic Technology Corp., Cixi | 2016
Out-of-stock
Qin Xu
Human Drug Form 483
FDA 483 DHHS/PSC/Supply Center, Perry Point | 2016
Out-of-stock
Qin Xu
Human Drug Form 483
Co-Investigators (20)
- Jaison J. Eapen, FDA Investigator
- Daniel J. Deciero, FDA Investigator
- Jonathan W. Chapman, FDA Investigator
- Djamila Harouaka, FDA Investigator
- Arsen Karapetyan, FDA Investigator
- Peter E. Baker, FDA Investigator
- Steven P. Donald, FDA Investigator
- Eric L. Dong, FDA Investigator
- Deyaa Shaheen, FDA Investigator
- Nebil A. Oumer, FDA Investigator
- Jessica L. Pressley, FDA Investigator
- Rachel C. Harrington, FDA Investigator
- Nicole E. Knowlton, FDA Investigator
- Toyin B. Oladimeji, FDA Investigator
- Pratik S. Upadhyay, FDA Investigator
- Conrad M. Guardia, FDA Investigator
- Laurissa S. Flowers, FDA Investigator
- Clarice J. Ahn, FDA Investigator
- Julie A. Silberberg, FDA Investigator
- Amanda B. Athey, FDA Investigator